Project Grant S10OD038303
- Federal Grant Award Summary Virginia Commonwealth University (VCU) received a $749,998 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351), awarded on July 15, 2025, with completion scheduled for July 14, 2026. The grant funds the acquisition and installation of a new state-of-the-art high-performance computing (HPC) cluster to replace VCU's aging 9-year-old FENN cluster dedicated to biomedical research. The...
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,089,778 to the University of Colorado Boulder (CU-Boulder) to purchase a high-resolution liquid chromatography-mass spectrometry (LC-MS) system. The new Waters Select Series Cyclic Ion Mobility QTOF (SS-CIMS) instrument will support advanced analytical capabilities for small molecule and biomolecule analysis, including high-resolution accurate mass...
- This Project Grant award of $348,724.00 from the U.S. Department of Health and Human Services National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), will enable Auburn University to acquire a shared Agilent 6546 LC-QTOF (Liquid Chromatography-Quadrupole Time-of-Flight) mass spectrometer. This state-of-the-art instrument will replace an outdated 15-year-old mass spectrometer, significantly enhancing the university's biomedical research capabilities across a...
- Christopher Newport University was awarded a $305,832 Project Grant from the National Science Foundation Office of Integrative Activities to acquire a liquid chromatography-quadrupole time-of-flight mass spectrometer. The award is part of the Integrative Activities program, which aims to enhance the competitiveness of the nation's research through activities that build STEM capacity and broaden participation in research and education. The mass spectrometer will support multidisciplinary research...
- Federal Project Grant Award Summary Virginia Commonwealth University received a $403,586 Project Grant from the National Cancer Institute (Cancer Biology Research program, CFDA 93.396) beginning August 1, 2025, and concluding July 31, 2027. The award supports research to develop codon-specific isotope labeling technology for nuclear magnetic resonance (NMR) resonance assignment. This novel methodology addresses critical obstacles in characterizing intrinsically disordered proteins (IDPs),...
- This $600,000 Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will provide funding to Georgia Tech Research Corporation to acquire a Bruker timsTOF HT mass spectrometer with a nanoelute 2 UHPLC system. This high-performance mass spectrometry instrumentation will upgrade the proteomics capabilities of the Systems Mass Spectrometry Core (SYMS-C) facility at Georgia Tech. The new instrumentation will support several...
- The National Science Foundation (NSF) awarded a $460,000 Project Grant under its Integrative Activities program (CFDA 47.083) to Central Michigan University (CMU) to acquire a Liquid Chromatography-Electrospray Ionization-Quadrupole Time of Flight Mass Spectrometer (LC-ESI-QTOF MS). This state-of-the-art instrument will facilitate advanced research and training in areas including synthetic chemistry, biochemistry, polymer science, and materials science at CMU. The LC-ESI-QTOF MS will enable...
- Federal Project Grant Award Summary Virginia Commonwealth University received a $248,999 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2028. This award supports research investigating the mechanotransduction regulation of cellular metabolism in idiopathic pulmonary fibrosis (IPF), a progressive scarring disease with limited therapeutic options. The research...
- Federal Project Grant Award Summary Emory University received a $747,569 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire an ultra high-performance liquid chromatograph coupled with a SCIEX triple quadrupole 7500 tandem mass spectrometer (LC-MS/MS) system. The instrument was acquired for installation in the Targeted Analysis Core (TAC) within the Rollins School of Public Health at Emory...
- Federal Grant Award Summary Virginia Commonwealth University received a $208,311 Project Grant award dated September 12, 2025, from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental biomedical research examining the role of C18-ceramide in iron-dependent cell death. The project, titled "C18-Ceramide as an Essential Factor in Iron Dependent Cell Death," will be conducted in Virginia through...
Virginia Commonwealth University (VCU) and Massey Comprehensive Cancer Center received a $489,354 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) for the period of June 1, 2026 through May 31, 2027. The award funds the acquisition of a SCIEX 7500+ System—QTRAP (Triple Quadrupole with Ion Trap) activated mass spectrometer for the Virginia Commonwealth University Lipidomics and Metabolomics Core (VLMC). This instrument will enhance the core facility's analytical capabilities to support ongoing research in lipid metabolism, metabolomics, and bioactive lipid signaling across multiple investigator groups at both institutions. The SCIEX 7500+ system will provide increased sensitivity and analytical flexibility compared to the facility's existing instrumentation, enabling targeted quantitative analysis of low-abundance metabolites and complex lipid structures. Key research applications include analysis of polar metabolites involved in the tricarboxylic acid cycle, glycolysis, amino acid metabolism, nucleotides, and energy equivalents; investigation of sphingolipid biosynthesis pathways and protein interactions; and evaluation of subcellular lipid compartmentation. As a recognized center for bioactive sphingolipid research, the facility will leverage this high-capacity ion trap technology to support exploratory and targeted lipidomics and metabolomics projects requiring exceptional sensitivity for small sample volumes and low-abundance analytes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $489.4k | 6/1/26 |